Finance Watch: A Summer Slowdown? Not For Venture Capital Mega-Rounds

Eight Firms Raised $100m Or More Since Last Week Of July

Private Company Edition: The latest $100m-plus VC financings include $112.5m for PepGen, Deep Genomics’ $180m series C round and a $166m series D for Rakuten Medical. Also, Lumira Ventures raised a $220m fourth fund and will manage a separate $35m fund backed by Angelini Pharma.

Venture capital mega-rounds of $100m or more are driving record levels of VC investment in biopharmaceutical companies, and these big financings have not taken a summer break.

The last week of July brought five, including a $153m series C round for Artios Pharma Limited on 27...